InspireMD, Inc.
For the period ended Sep 30, 2025. Filed Nov 10, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2025 · Filed Nov 10, 2025
NSPR$0.70+8.9%Stored close · as of Nov 6, 2026
Contents
Item 1. Condensed Consolidated Balance Sheets
CONDENSED CONSOLIDATED BALANCE SHEETS
(U.S. dollars in thousands, except share and per share data)
| September 30, | December 31, | |
|---|---|---|
| 2025 | 2024 | |
| ASSETS | ||
| CURRENT ASSETS: | ||
| Cash and cash equivalents | $63,403 | $18,916 |
| Marketable securities | - | 15,721 |
| Accounts receivable: | ||
| Trade, net | 1,961 | 1,572 |
| Other | 475 | 682 |
| Prepaid expenses | 945 | 1,060 |
| Inventory | 3,607 | 2,570 |
| TOTAL CURRENT ASSETS | 70,391 | 40,521 |
| NON-CURRENT ASSETS: | ||
| Long term deposit | 438 | 426 |
| Property, plant and equipment, net | 3,403 | 2,371 |
| Operating lease right of use assets | 2,915 | 2,360 |
| Fund in respect of employee rights upon retirement | 1,325 | 1,129 |
| TOTAL NON-CURRENT ASSETS | 8,081 | 6,286 |
| TOTAL ASSETS | $78,472 | $46,807 |
CONDENSED CONSOLIDATED BALANCE SHEETS
(U.S. dollars in thousands other than share and per share data)
| September 30, | December 31, | |
|---|---|---|
| 2025 | 2024 | |
| LIABILITIES AND EQUITY | ||
| CURRENT LIABILITIES: | ||
| Accounts payable and accruals: | ||
| Trade | 1,753 | 1,254 |
| Other | 9,063 | 6,424 |
| TOTAL CURRENT LIABILITIES | 10,816 | 7,678 |
| LONG-TERM LIABILITIES- | ||
| Operating lease liabilities net of current maturities | 2,367 | 1,796 |
| Liability for employees’ rights upon retirement and others | 1,175 | 1,247 |
| TOTAL LONG-TERM LIABILITIES | 3,542 | 3,043 |
| TOTAL LIABILITIES | 14,358 | 10,721 |
| COMMITMENTS AND CONTINGENT LIABILITIES | - | - |
| EQUITY: | ||
| Common stock, par value $0.0001 per share; 150,000,000 shares authorized at September 30, 2025 and December 31, 2024; 41,919,141 and 26,611,033 shares issued and outstanding at September 30, 2025 and December 31, 2024, respectively | 4 | 3 |
| Preferred C shares, par value $0.0001 per share; 1,172,000 shares authorized at September 30, 2025 and December 31, 2024; 1,718 shares issued and outstanding at September 30, 2025 and December 31 2024, respectively | -* | -* |
| Additional paid-in capital | 354,641 | 289,589 |
| Accumulated deficit | (290,531) | (253,506) |
| Total equity | 64,114 | 36,086 |
| Total liabilities and equity | $78,472 | $46,807 |
| * | Represents an amount less than $1 thousand |
|---|
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.